CA Stock MarketDetailed Quotes
KOVO Kovo Healthtech Corp
- 0.025
- +0.005+25.00%
15min DelayTrading Jul 23 09:57 ET
1.44MMarket Cap-173P/E (TTM)
0.025High0.025Low1.00KVolume0.025Open0.020Pre Close25.00Turnover0.12052wk High0.01%Turnover Ratio57.54MShares0.01552wk Low-0.144EPS TTM478.05KFloat Cap1.150Historical HighLossP/E (Static)19.12MShs Float0.015Historical Low-0.119EPS LYR0.00%Amplitude--Dividend TTM-0.43P/B1Lot Size--Div YieldTTM
Kovo Healthtech Corp Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -114.29%-780K | -70.71%-717K | 96.71%-8K | -131.37%-32K | 32.76%-312K | -291.58%-364K | 58.00%-420K | 63.89%-243K | 129.65%102K | -3,414.29%-464K |
| Net income from continuing operations | -151.17%-2.16M | -1,773.60%-4.68M | -2,298.72%-1.72M | -460.63%-797K | -505.53%-1.31M | -158.43%-858K | 90.74%-250K | 105.86%78K | 146.43%221K | 58.67%-217K |
| Operating gains losses | ---- | 168.65%427K | -133.33%-1K | ---- | --428K | ---- | -70.88%-622K | 100.81%3K | -6,788.89%-620K | ---- |
| Depreciation and amortization | 53.79%223K | 25.47%793K | 69.18%247K | 14.53%205K | 29.61%197K | -6.45%145K | 7.30%632K | -28.78%146K | 19.33%179K | 34.51%152K |
| Remuneration paid in stock | -44.83%16K | -49.48%244K | -100.39%-1K | -64.41%21K | 45.52%195K | -9.38%29K | 228.57%483K | 416.00%258K | 73.53%59K | 688.24%134K |
| Deferred tax | ---- | 94.42%-37K | ---- | ---- | ---- | ---- | ---663K | ---- | ---- | ---- |
| Other non cashItems | 1,669.39%867K | -70.24%75K | -83.05%10K | -83.93%9K | -92.65%5K | -23.44%49K | -54.01%252K | -52.80%59K | 64.71%56K | -81.22%68K |
| Change In working capital | -0.74%269K | 1,078.17%2.47M | 1,300.00%1.49M | 155.56%529K | 129.21%177K | 0.00%271K | -215.00%-252K | 40.67%-124K | 368.83%207K | -2,120.00%-606K |
| -Change in receivables | 231.58%63K | 497.73%175K | 107.69%8K | -81.82%48K | 155.25%100K | 182.61%19K | 69.44%-44K | 41.90%-104K | 361.39%264K | -129.11%-181K |
| -Change in payables and accrued expense | -18.90%206K | 1,207.25%2.29M | 7,889.47%1.48M | 943.86%481K | 130.20%77K | 104.84%254K | -340.70%-207K | -26.67%-19K | -337.50%-57K | -319.83%-255K |
| -Change in other working capital | ---- | -100.00%-2K | --0 | ---- | ---- | -101.18%-2K | 95.45%-1K | ---- | ---- | -2,328.57%-170K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -114.29%-780K | -70.71%-717K | 96.30%-9K | -132.35%-33K | 33.48%-312K | -291.58%-364K | 58.00%-420K | 63.89%-243K | 129.65%102K | -3,450.00%-469K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -23.08%-96K | -859.53%-3.27M | -45.88%-124K | 27.33%-125K | -6,446.67%-2.95M | -100.00%-78K | 75.57%-341K | 94.48%-85K | -2,011.11%-172K | -127.78%-45K |
| Net PPE purchase and sale | --0 | 57.95%-37K | 10.00%-9K | 97.22%-2K | -16.67%-7K | ---19K | ---88K | ---10K | ---72K | ---6K |
| Net intangibles purchas and sale | -57.38%-96K | -50.77%-392K | -51.95%-117K | -22.55%-125K | -122.50%-89K | -48.78%-61K | -59.51%-260K | -87.80%-77K | -148.78%-102K | 0.00%-40K |
| Net business purchase and sale | ---- | ---2.85M | --0 | --0 | ---2.85M | ---- | --0 | --0 | --0 | --0 |
| Net other investing changes | ---- | 0.00%7K | 50.00%3K | 0.00%2K | 0.00%1K | 0.00%2K | -46.15%7K | --2K | --2K | --1K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -23.08%-96K | -859.53%-3.27M | -44.71%-123K | 27.33%-125K | -6,444.44%-2.95M | -100.00%-78K | 75.57%-341K | 94.48%-85K | -2,011.11%-172K | -127.78%-45K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 716.78%1.17M | 358.09%3.4M | 51.82%-53K | 37.70%-76K | 203.86%3.39M | 202.14%143K | -74.88%742K | -104.46%-110K | 20.26%-122K | 1,110.87%1.11M |
| Net issuance payments of debt | 716.78%1.17M | -75.47%182K | 50.91%-54K | 37.70%-76K | -84.83%169K | 202.14%143K | -44.59%742K | -107.73%-110K | 5.43%-122K | 340.60%1.11M |
| Net common stock issuance | ---- | --3.22M | --1K | --0 | --3.22M | ---- | --0 | --0 | --0 | --0 |
| Net other financing activities | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 716.08%1.17M | 358.09%3.4M | 51.82%-53K | 37.70%-76K | 203.86%3.39M | 202.14%143K | -74.88%742K | -104.46%-110K | 20.26%-122K | 1,110.87%1.11M |
| Net cash flow | ||||||||||
| Beginning cash position | -85.26%102K | -2.67%692K | -74.60%287K | -60.59%521K | -45.57%393K | -2.67%692K | 364.71%711K | 147.81%1.13M | 40.04%1.32M | 6.80%722K |
| Current changes in cash | 197.32%291K | -3,005.26%-590K | 57.76%-185K | -21.88%-234K | -78.67%128K | -2,818.18%-299K | -103.41%-19K | -271.76%-438K | 60.66%-192K | 123.88%600K |
| End cash Position | 0.00%393K | -85.26%102K | -85.26%102K | -74.60%287K | -60.59%521K | -45.57%393K | -2.67%692K | -2.67%692K | 147.81%1.13M | 40.04%1.32M |
| Free cash from | -97.30%-876K | -49.22%-1.15M | 59.09%-135K | -122.22%-160K | 20.78%-408K | -397.99%-444K | 33.96%-768K | 53.78%-330K | 81.30%-72K | -1,880.77%-515K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg